Current role
James Sullivan
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
enGene Therapeutics Inc. (ENGN)
Proxy statement
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | enGene Therapeutics Inc. (ENGN) | Chief Scientific Officer | $379,500 | $896,242 |
| 2022 | enGene Therapeutics Inc. (ENGN) | Chief Scientific Officer | $279,250 | $439,866 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.